Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
ENCORIUM GROUP Add to My Watchlist (NSDQ: ENCO) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Encorium Group 0.25 - (+0.00%) 85,770
One Glenhardie Corporate Ctr
1275 Drummers Lane Suite 300
Wayne, PA 19087 US
(610) 975-9533
(610) 975-9556 fax
www.encorium.com
CEO Dr. Kai Lindevall, M.D., Ph.D.
Auditor Deloitte & Touche LLP
Exchange Traded NQ
ISIN Number US29257R1095
CIK Number 856569
NAICS Code 541711
Business Summary
A clinical research organization that engages in the design and management of complex clinical trials for the pharmaceutical, biotechnology and medical device industries.
Number of Employees 226
Share Fundamentals
Market Cap 6.58M
Shares Outstanding 26.33M
Float 13.02M
Short Interest 164.58K
Financial Strength
Revenue (TTM) $27,887,360
Earnings (TTM) -$16,879,322
Quick Ratio 0.4:1
Current Ratio 0.6:1
Total Debt/Equity 0.9:1
Profitability
Gross Margin 57.4%
EBITDA Margin -11.0%
Profit Margin -56.7%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs